Novartis Aims to Have Dengue Fever Drugs in Clinical Trials by 2011 - WSJ.com
Interesting news from Novartis. Dengue rears its ugly head in the south US from time to time, usually in Texas. In our West Nile-endemic society, which infects thousands, it's good to remember that WNV is really a relatively mild vector-borne disease. From the article: Dengue infects 50 MILLION each year.
Monday, March 23, 2009
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment